Global Infectious Disease In-Vitro Diagnostics Market

Global Infectious Disease In-Vitro Diagnostics Market Size, Trends, and Analysis- Forecasts to 2026 By Product (Instruments [MRSA, Streptococcus, Clostridium Difficile, VRE, CRE, Respiratory Virus, Candida, TB and Drug-resistant TB, Gastro-intestinal Panel Testing, Chlamydia, Gonorrhea, HPV, HIV, Hepatitis C, Hepatitis B, COVID-19, Others], Reagents [MRSA, Streptococcus, Clostridium Difficile, VRE, CRE, Respiratory Virus, Candida, TB and Drug-resistant TB, Gastro-intestinal Panel Testing, Chlamydia, Gonorrhea, HPV, HIV, Hepatitis C, Hepatitis B, COVID-19, Others], Services [MRSA, Streptococcus, Clostridium Difficile, VRE, CRE, Respiratory Virus, Candida, TB and Drug-resistant TB, Gastro-intestinal Panel Testing, Chlamydia, Gonorrhea, HPV, HIV, Hepatitis C, Hepatitis B, COVID-19, Others]), By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Others), By Application (MRSA, Streptococcus, Clostridium Difficile, VRE, CRE, Respiratory Virus, Candida, TB and Drug-resistant TB, Gastro-intestinal Panel Testing, Chlamydia, Gonorrhea, HPV, HIV, Hepatitis C, Hepatitis B, COVID-19, Others), By End-use (Point of care, Central Laboratories, Others), By Region (North America, Europe, Asia Pacific, MEA, and CSA).

Category Healthcare

Format

This report was recently updated on October 23 2024 with the latest and most recent market numbers

Global Infectious Disease In-Vitro Diagnostics Market: Insights

With the rising population rate across the globe, the number of infectious diseases reported every single day is increasing rapidly. With the increasing rate of infectious diseases being reported, the need for various effective diagnostics methods has become a vital part of the diagnostic industry. In-Vitro diagnostics are tests that primarily detect various infectious diseases or infections. These diagnostic tests are typically undertaken in test tubes or other equipment/ instruments, unlike the Vitro diagnostic tests which are undertaken or conducted within the body to detect any presence of infectious disease or other infection.

The ratio of life expectancy of the population above the age of 60 years is rapidly growing in the market. As per the United Nations (The UN) reports of 2018, the elderly population of above 60 years of age is numbered to be approximately 962 million people. Moreover, according to the World Bank database, the 2019 reports show that people aged 60 and above hold 9.09% of the total population. This percentage is expected to witness an increase, especially in the Asia Pacific region. Hence the improved lifestyle and increased life expectancy of the elderly population, is considered to be a major driving factor. Geriatric population is highly vulnerable to getting exposed to various infectious diseases, thus accelerating growth for in-vitro diagnostics market.

The number of various infectious diseases prevailing is exponentially increasing, affecting many individuals across the world. The in-vitro diagnostics for infectious diseases serve a crucial diagnostic step in the medical and healthcare industry, as by carrying out these diagnostics, countries and their respective healthcare departments are enabled to bring control over the increasing numbers of diseases and find the cure. The 2018 database presented by the National Center for Health Statistics showcases that a country like the United States diagnosed approximately 37377 HIV/AIDS cases by undertaking in-vitro diagnostics and diagnosed approximately 12474 type A hepatitis 115045 STD cases, 375 rubella cases, and many more such infectious diseases. This increasing spread of infectious diseases accelerates growth and requirement in infectious disease in-vitro diagnostics market.

In the pandemic situation brought by the contagious virus of COVID-19, the demand for in-vitro diagnostics is expected to witness rapid escalation, thus witnessing higher growth rates. Various forms and types of infectious disease in-vitro diagnostics are currently being utilized to test the presence of coronavirus in individuals across the globe.

global infectious disease in-vitro diagnostics market

Global Infectious Disease In-Vitro Diagnostics Market: By Product

Based on product type, the infectious disease in-vitro diagnostics market is segmented into instruments, reagents, and services. Reagents holds a dominant position in the market, and is utilized the most due to its significant importance and necessity in the medical and diagnostics sector. These reagents are the finest chemical products to detect the presence or absence of any external substance, and a color change notifies this presence or absence, and this color depicts the concentration of the external substance, thus indicating the severity of the disease. Considering these features facilitated by reagent-based products, they are widely utilized by professionals to serve accurate diagnostic results with absolute precision. These products are also cost-effective and less time-consuming and deliver the test results rapidly, unlike other products used for in-vitro diagnostics. Also, followed by reagents, instruments are expected to witness fast growth within the infectious diseases in-vitro diagnostics market due to their accessible operational and less complex features, facilitating the tests to be carried out in any environment.

Global Infectious Disease In-Vitro Diagnostics Market: By Technology

Based on the technology, the infectious disease IVD market is classified into Immunoassay, Molecular Diagnostics, Microbiology, and Others. Amongst these, the immunoassay technology is analyzed the to be the largest share holder in the market. This technology facilitates a considerably fast, simplistic, and cost-effective diagnosis compared to the rest of the technologies.

Global Infectious Disease In-Vitro Diagnostics Market: By Application

Based on application, the market is segmented into MRSA, Streptococcus, Clostridium Difficile, VRE, CRE, Respiratory Virus, Candida, TB and Drug-resistant TB, Gastro-intestinal Panel Testing, Chlamydia, Gonorrhea, HPV, HIV, Hepatitis C, Hepatitis B, COVID-19, and Others. As of 2020, COVID-19 has required most of the IVD applications compared to the rest of the applications, and thus this makes it the largest shareholding segment in the market. Currently, due to the availability of few very essential In-Vitro diagnostics like assays to diagnose SARS-CoV-2 nucleic acid and rapid diagnostic test to detect the presence of IgM/IgG to SARS-CoV-2, the application of these for testing COVID-19 cases has drastically increased. It is also expected to have a constant increase in growth during the forecasted period of 2021-2026.

Global Infectious Disease In-Vitro Diagnostics Market: By End Users

Based on the end-users, the market is segmented into point of care, central laboratories, and others. Central laboratories are the most prominent end-users of the infectious disease in-vitro diagnostics market, thus hold the largest share. With drastically increasing research and development and the emergence of many professionals and practitioners, there has been a drastic demand from and growth within the central laboratories segment.

asia pacific infectious disease in-vitro diagnostics market

Global Infectious Disease In-Vitro Diagnostics Market: By Regions

Based on regional segmentation, North America holds the largest share in the market. Countries like the United States and Canada have always been very proactive in advancing their medical and healthcare sectors by introducing various diagnostics and tests to detect infectious diseases and find a cure for them. Also, presently, the United States has been the worst hit and affected country due to the COVID-19 pandemic and has been the biggest utilizer of infectious disease in-vitro diagnostics.

Followed by the North American region, Asia Pacific is expected to witness rapid and fast growth in the market during the forecasted period of 2021-2026. Countries in the Asia Pacific region have the world’s largest population rates and the largest geriatric population compared to the rest of the world. These countries are gradually experiencing improvements and developments in their technological application within the healthcare and diagnosis market, thus boosting the growth for IVDs. These countries have been some of the worst affected countries since last many decades when it comes to various epidemics, pandemics, and other contiguous diseases like Swine Flu, Influenza, or even diseases like HIV/AIDS. Presently, countries like India and Korea are some of the most and worst-affected countries due to the COVID-19 virus, followed by the USA from the North American region. These factors and the increase in the number of end-users and verticals undertaking the IVDs are accelerating the growth in the infectious disease in-vitro diagnostics (IVD) market.

Global Infectious Disease In-Vitro Diagnostics Market: By Share & Competitor Analysis

BD, Abbott, Siemens Healthineers, Danaher, bioMérieux SA, AG,OraSure Technologies, Inc., Quidel Corporation, Hologic, Inc. (Gen Probe), QIAGEN, F. Hoffmann-La Roche, Ltd., and Bio-Rad Laboratories, Inc., are some of the prominent competitors in the market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1 Methodology

1.1 Market Scope & Definitions

1.2 Estimates & Forecast Calculation

1.3 Historical Data Overview and Validation

1.4 Data Sources

1.4.1 Secondary

1.4.2 Primary

Chapter 2 Report Outlook

2.1 Infectious Disease In-Vitro Diagnostics Industry Overview, 2021-2026

2.1.1 Industry Overview

2.1.2 Product Overview

2.1.3 Application Overview

2.1.4 End-User Overview

2.1.5 Technology Overview

2.1.6 Regional Overview

Chapter 3 Infectious Disease In-Vitro Diagnostics Market Trends

3.1 Market Segmentation

3.2 Industry Background, 2016-2026

3.3 Market Key Trends

3.3.1 Positive Trends

3.3.1.1 Rapidly rising COVID-19 infection across the globe

3.3.2 Industry Challenges

3.3.2.1 Lack of adequate infrastructure and automated laboratory systems in developing nations

3.4 Prospective Growth Scenario

3.4.1 Product Growth Scenario

3.4.2 Application Growth Scenario

3.4.3 End-User Growth Scenario

3.4.4 Technology Growth Scenario

3.5 COVID-19 Influence over Industry Growth

3.6 Porter’s Analysis

3.7 PESTEL Analysis

3.8 Value Chain & Supply Chain Analysis

3.9 Regulatory Framework

3.9.1 North America

3.9.2 Europe

3.9.3 APAC

3.9.4 LATAM

3.9.5 MEA

3.10 Technology Overview

3.11 Market Share Analysis, 2020

3.11.1 Company Positioning Overview, 2020

Chapter 4 Infectious Disease In-Vitro Diagnostics Market, By Product

4.1 Product Outlook

4.2 Instruments

4.2.1 Market Size, By Region, 2016-2026 (USD Million)

4.3 Reagents

4.3.1 Market Size, By Region, 2016-2026 (USD Million)

4.4 Services

4.4.1 Market Size, By Region, 2016-2026 (USD Million)

Chapter 5 Infectious Disease In-Vitro Diagnostics Market, By Application

5.1 End-User Outlook

5.2 MRSA, Streptococcus

5.2.1 Market Size, By Region, 2016-2026 (USD Million)

5.3 Clostridium Difficile

5.3.1 Market Size, By Region, 2016-2026 (USD Million)

5.4 VRE

5.4.1 Market Size, By Region, 2016-2026 (USD Million)

5.5 CRE

5.5.1 Market Size, By Region, 2016-2026 (USD Million)

5.6 Respiratory Virus

5.6.1 Market Size, By Region, 2016-2026 (USD Million)

5.7 Candida

5.7.1 Market Size, By Region, 2016-2026 (USD Million)

5.8 TB and Drug-resistant TB

5.8.1 Market Size, By Region, 2016-2026 (USD Million)

5.9 Gastro-intestinal Panel Testing

5.9.1 Market Size, By Region, 2016-2026 (USD Million)

5.10 Gonorrhea

5.10.1 Market Size, By Region, 2016-2026 (USD Million)

5.11 HPV

5.11.1 Market Size, By Region, 2016-2026 (USD Million)

5.12 HIV

5.12.1 Market Size, By Region, 2016-2026 (USD Million)

5.13 Hepatitis C

5.13.1 Market Size, By Region, 2016-2026 (USD Million)

5.14 Hepatitis B

5.14.1 Market Size, By Region, 2016-2026 (USD Million)

5.15 COVID-19

5.15.1 Market Size, By Region, 2016-2026 (USD Million)

Chapter 6 Infectious Disease In-Vitro Diagnostics Market, By End-User

6.1 Point of Care

6.1.1 Market Size, By Region, 2016-2026 (USD Million)

6.2 Central Laboratories

6.2.1 Market Size, By Region, 2016-2026 (USD Million)

Chapter 7 Infectious Disease In-Vitro Diagnostics Market, By Technology

7.1 Immunology

7.1.1 Market Size, By Region, 2016-2026 (USD Million)

7.2 Molecular Diagnostics

7.2.1 Market Size, By Region, 2016-2026 (USD Million)

7.2 Microbiology

7.2.1 Market Size, By Region, 2016-2026 (USD Million)

7.2 Others

7.2.1 Market Size, By Region, 2016-2026 (USD Million)

Chapter 8 Infectious Disease In-Vitro Diagnostics Market, By Region

8.1 Regional outlook

8.2 North America

8.2.1 Market Size, By Country 2016-2026 (USD Million)

8.2.2 Market Size, By Product, 2016-2026 (USD Million)

8.2.3 Market Size, By Application, 2016-2026 (USD Million)

8.2.4 Market Size, By End-User, 2016-2026 (USD Million)

8.2.5 Market Size, By Technology, 2016-2026 (USD Million)

8.2.6 U.S.

8.2.6.1 Market Size, By Product, 2016-2026 (USD Million)

8.2.4.2 Market Size, By Application, 2016-2026 (USD Million)

8.2.4.3 Market Size, By End-User, 2016-2026 (USD Million)

Market Size, By Technology, 2016-2026 (USD Million)

8.2.7 Canada

8.2.7.1 Market Size, By Product, 2016-2026 (USD Million)

8.2.7.2 Market Size, By Application, 2016-2026 (USD Million)

8.2.7.3 Market Size, By End-User, 2016-2026 (USD Million)

8.2.7.4 Market Size, By Technology, 2016-2026 (USD Million)

8.3 Europe

8.3.1 Market Size, By Country 2016-2026 (USD Million)

8.3.2 Market Size, By Product, 2016-2026 (USD Million)

8.3.3 Market Size, By Application, 2016-2026 (USD Million)

8.3.4 Market Size, By End-User, 2016-2026 (USD Million)

8.3.5 Market Size, By Technology, 2016-2026 (USD Million)

8.3.6 Germany

8.3.6.1 Market Size, By Product, 2016-2026 (USD Million)

8.3.6.2 Market Size, By Application, 2016-2026 (USD Million)

8.3.6.3 Market Size, By End-User, 2016-2026 (USD Million)

8.3.6.4 Market Size, By Technology, 2016-2026 (USD Million)

8.3.7 UK

8.3.7.1 Market Size, By Product, 2016-2026 (USD Million)

8.3.7.2 Market Size, By Application, 2016-2026 (USD Million)

8.3.7.3 Market Size, By End-User, 2016-2026 (USD Million)

8.3.7.4 Market Size, By Technology, 2016-2026 (USD Million)

8.3.8 France

8.3.8.1 Market Size, By Product, 2016-2026 (USD Million)

8.3.8.2 Market Size, By Application, 2016-2026 (USD Million)

8.3.8.3 Market Size, By End-User, 2016-2026 (USD Million)

8.3.8.4 Market Size, By Technology, 2016-2026 (USD Million)

8.3.9 Italy

8.3.9.1 Market Size, By Product, 2016-2026 (USD Million)

8.3.9.2 Market Size, By Application, 2016-2026 (USD Million)

8.3.9.3 Market Size, By End-User, 2016-2026 (USD Million)

8.3.9.4 Market Size, By Technology, 2016-2026 (USD Million)

8.3.10 Spain

8.3.10.1 Market Size, By Product, 2016-2026 (USD Million)

8.3.10.2 Market Size, By Application, 2016-2026 (USD Million)

8.3.10.3 Market Size, By End-User, 2016-2026 (USD Million)

8.3.10.4 Market Size, By Technology, 2016-2026 (USD Million)

8.3.11 Russia

8.3.11.1 Market Size, By Product, 2016-2026 (USD Million)

8.3.11.2 Market Size, By Application, 2016-2026 (USD Million)

8.3.11.3 Market Size, By End-User, 2016-2026 (USD Million)

8.3.11.4 Market Size, By Technology, 2016-2026 (USD Million)

8.4 Asia Pacific

8.4.1 Market Size, By Country 2016-2026 (USD Million)

8.4.2 Market Size, By Product, 2016-2026 (USD Million)

8.4.3 Market Size, By Application, 2016-2026 (USD Million)

8.4.4 Market Size, By End-User, 2016-2026 (USD Million)

8.4.5 Market Size, By Technology, 2016-2026 (USD Million)

8.4.6 China

8.4.6.1 Market Size, By Product, 2016-2026 (USD Million)

8.4.6.2 Market Size, By Application, 2016-2026 (USD Million)

8.4.6.3 Market Size, By End-User, 2016-2026 (USD Million)

8.4.6.4 Market Size, By Technology, 2016-2026 (USD Million)

8.4.7 India

8.4.7.1 Market Size, By Product, 2016-2026 (USD Million)

8.4.7.2 Market Size, By Application, 2016-2026 (USD Million)

8.4.7.3 Market Size, By End-User, 2016-2026 (USD Million)

8.4.7.4 Market Size, By Technology, 2016-2026 (USD Million)

8.4.8 Japan

8.4.8.1 Market Size, By Product, 2016-2026 (USD Million)

8.4.8.2 Market Size, By Application, 2016-2026 (USD Million)

8.4.8.3 Market Size, By End-User, 2016-2026 (USD Million)

8.4.8.4 Market Size, By Technology, 2016-2026 (USD Million)

8.4.9 Australia

8.4.9.1 Market Size, By Product, 2016-2026 (USD Million)

8.4.9.2 Market size, By Application, 2016-2026 (USD Million)

8.4.9.3 Market Size, By End-User, 2016-2026 (USD Million)

8.4.9.4 Market Size, By Technology, 2016-2026 (USD Million)

8.4.10 South Korea

8.4.10.1 Market Size, By Product, 2016-2026 (USD Million)

8.4.10.2 Market Size, By Application, 2016-2026 (USD Million)

8.4.10.3 Market Size, By End-User, 2016-2026 (USD Million)

8.4.10.4 Market Size, By Technology, 2016-2026 (USD Million)

8.5 Latin America

8.5.1 Market Size, By Country 2016-2026 (USD Million)

8.5.2 Market Size, By Product, 2016-2026 (USD Million)

8.5.3 Market Size, By Application, 2016-2026 (USD Million)

8.5.4 Market Size, By End-User, 2016-2026 (USD Million)

8.5.5 Market Size, By Technology, 2016-2026 (USD Million)

8.5.6 Brazil

8.5.6.1 Market Size, By Product, 2016-2026 (USD Million)

8.5.6.2 Market Size, By Application, 2016-2026 (USD Million)

8.5.6.3 Market Size, By End-User, 2016-2026 (USD Million)

8.5.6.4 Market Size, By Technology, 2016-2026 (USD Million)

8.5.7 Mexico

8.5.7.1 Market Size, By Product, 2016-2026 (USD Million)

8.5.7.2 Market Size, By Application, 2016-2026 (USD Million)

8.5.7.3 Market Size, By End-User, 2016-2026 (USD Million)

8.5.7.4 Market Size, By Technology, 2016-2026 (USD Million)

8.5.8 Argentina

8.5.8.1 Market Size, By Product, 2016-2026 (USD Million)

8.5.8.2 Market Size, By Application, 2016-2026 (USD Million)

8.5.8.3 Market Size, By End-User, 2016-2026 (USD Million)

8.5.8.4 Market Size, By Technology, 2016-2026 (USD Million)

8.6 MEA

8.6.1 Market Size, By Country 2016-2026 (USD Million)

8.6.2 Market Size, By Product, 2016-2026 (USD Million)

8.6.3 Market Size, By Application, 2016-2026 (USD Million)

8.6.4 Market Size, By End-User, 2016-2026 (USD Million)

8.6.5 Market Size, By Technology, 2016-2026 (USD Million)

8.6.6 Saudi Arabia

8.6.6.1 Market Size, By Product, 2016-2026 (USD Million)

8.6.6.2 Market Size, By Application, 2016-2026 (USD Million)

8.6.6.3 Market Size, By End-User, 2016-2026 (USD Million)

8.6.6.4 Market Size, By Technology, 2016-2026 (USD Million)

8.6.7 UAE

8.6.7.1 Market Size, By Product, 2016-2026 (USD Million)

8.6.7.2 Market Size, By Application, 2016-2026 (USD Million)

8.6.7.3 Market Size, By End-User, 2016-2026 (USD Million)

8.6.7.4 Market Size, By Technology, 2016-2026 (USD Million)

8.6.8 South Africa

8.6.8.1 Market Size, By Product, 2016-2026 (USD Million)

8.6.8.2 Market Size, By Application, 2016-2026 (USD Million)

8.6.8.3 Market Size, By End-User, 2016-2026 (USD Million)

8.6.8.4 Market Size, By Technology, 2016-2026 (USD Million)

Chapter 9 Company Landscape

9.1 Competitive Analysis, 2020

9.2 BD

9.2.1 Company Overview

9.2.2 Financial Analysis

9.2.3 Strategic Positioning

9.2.4 Info Graphic Analysis

9.3 Abbott

9.3.1 Company Overview

9.3.2 Financial Analysis

9.3.3 Strategic Positioning

9.3.4 Info Graphic Analysis

9.4 Danaher

9.4.1 Company Overview

9.4.2 Financial Analysis

9.4.3 Strategic Positioning

9.4.4 Info Graphic Analysis

9.5 Siemens Healthineers

9.5.1 Company Overview

9.5.2 Financial Analysis

9.5.3 Strategic Positioning

9.5.4 Info Graphic Analysis

9.6 bioMérieux SA

9.6.1 Company Overview

9.6.2 Financial Analysis

9.6.3 Strategic Positioning

9.6.4 Info Graphic Analysis

9.7 OraSure Technologies, Inc

9.7.1 Company Overview

9.7.2 Financial Analysis

9.7.3 Strategic Positioning

9.7.4 Info Graphic Analysis

9.8 Quidel Corporation

9.8.1 Company Overview

9.8.2 Financial Analysis

9.8.3 Strategic Positioning

9.8.4 Info Graphic Analysis

9.9 Hologic, Inc

9.9.1 Company Overview

9.9.2 Financial Analysis

9.9.3 Strategic Positioning

9.9.4 Info Graphic Analysis

9.10 QIAGEN

9.10.1 Company Overview

9.10.2 Financial Analysis

9.10.3 Strategic Positioning

9.10.4 Info Graphic Analysis

9.11 Other Companies

9.11.1 Company Overview

9.11.2 Financial Analysis

9.11.3 Strategic Positioning

9.11.4 Info Graphic Analysis

The Global Infectious Disease In-Vitro Diagnostics Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

Infectious Disease In-Vitro Diagnostics Market

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Infectious Disease In-Vitro Diagnostics Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the global infectious disease in-vitro diagnostics market?

The global infectious disease in-vitro diagnostics market size is projected to grow at a CAGR of 4.6% during the forecast period (2021-2026).

Who are the major vendors in the infectious disease in-vitro diagnostics market?

Key and innovative vendors in the infectious disease in-vitro diagnostics market include BD, Abbott, Siemens Healthineers, Danaher, bioMérieux SA, AG,OraSure Technologies, Inc., Quidel Corporation, Hologic, Inc. (Gen Probe), QIAGEN, F. Hoffmann-La Roche, Ltd., and Bio-Rad Laboratories, Inc.

Which region has the highest market share in the infectious disease in-vitro diagnostics market?

North America is estimated to hold the highest market share in the infectious disease in-vitro diagnostics market.

What is the Covid-19 impact on future infectious disease in-vitro diagnostics manufacturers?

Globally, the Covid-19 impact on the future infectious disease in-vitro diagnostics market will be quite significant for the manufacturers since demand has fluctuated owing to lockdown in key nations throughout the world. North America would be leading because this region is been very proactive in advancing its medical and healthcare sectors. Subsequently, Asia Pacific will be growing the fastest because this region is gradually experiencing improvements and developments in its technological application within the healthcare and diagnosis market

What are the major drivers in the infectious disease in-vitro diagnostics market?

The major driving factors for the infectious disease in-vitro diagnostics market include the improved lifestyle and increased life expectancy of the elderly population; rising number of infectious diseases; increasing awareness about beneficial features attributed by IVDs.